Literature DB >> 2782236

Congenital myasthenic syndrome in the dog breed Gammel Dansk Hønsehund: clinical, electrophysiological, pharmacological and immunological comparison with acquired myasthenia gravis.

A Flagstad, W Trojaborg, S Gammeltoft.   

Abstract

The effect of anticholinesterase drugs on the clinical and electrophysiological features in a canine congenital myasthenic syndrome is compared with findings in acquired myasthenia gravis in dogs. Anticholinesterase treatment had no effect on muscle weakness or electrophysiological parameters in the congenital myasthenic syndrome in contrast to its effect on clinical signs and electrophysiological parameters in acquired myasthenia gravis. The lack of effect of anticholinesterase in congenital myasthenia suggests a presynaptic defect as the aetiological factor. No antibodies to acetylcholine receptors were found in the Danish dog breed Gammel Dansk Hønsehund with the myasthenic syndrome. This classifies the disease in the group of canine and human congenital myasthenic diseases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2782236      PMCID: PMC8142211     

Source DB:  PubMed          Journal:  Acta Vet Scand        ISSN: 0044-605X            Impact factor:   1.695


  25 in total

1.  Myasthenia in Springer Spaniel littermates.

Authors:  R P Johnson; A D Watson; J Smith; B J Cooper
Journal:  J Small Anim Pract       Date:  1975-10       Impact factor: 1.522

2.  Incrementing responses in myasthenia gravis.

Authors:  R F Mayer; I R Williams
Journal:  Arch Neurol       Date:  1974-07

3.  Clinical and physiological studies of the effect of guanidine of patients with myasthenia gravis.

Authors:  J C Brown; R J Johns
Journal:  Johns Hopkins Med J       Date:  1969-01

4.  Recessive mode of inheritance in myasthenia gravis in the Jack Russell terrier.

Authors:  M E Wallace; A C Palmer
Journal:  Vet Rec       Date:  1984-04-07       Impact factor: 2.695

5.  Congenital myasthenia in the Jack Russell terrier.

Authors:  A C Palmer; J V Goodyear
Journal:  Vet Rec       Date:  1978-11-04       Impact factor: 2.695

6.  A new hereditary neuromuscular disease in the dog breed "Gammel Dansk Honsehund". Genetic investigations.

Authors:  A Flagstad
Journal:  Hereditas       Date:  1982       Impact factor: 3.271

7.  Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases.

Authors:  A Vincent; S G Cull-Candy; J Newsom-Davis; A Trautmann; P C Molenaar; R L Polak
Journal:  Muscle Nerve       Date:  1981 Jul-Aug       Impact factor: 3.217

8.  A hereditary neuromuscular disorder in dogs.

Authors:  W Trojaborg; A Flagstad
Journal:  Muscle Nerve       Date:  1982       Impact factor: 3.217

9.  Recently recognized congenital myasthenic syndromes: (a) end-plate acetylcholine (ACh) esterase deficiency (b) putative abnormality of the ACh induced ion channel (c) putative defect of ACh resynthesis or mobilization - clinical features, ultrastructure and cytochemistry.

Authors:  A G Engel; E H Lambert; D M Mulder; M R Gomez; J N Whitaker; Z Hart; K Sahashi
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

10.  Inheritance of congenital myasthenia gravis in smooth fox terrier dogs.

Authors:  L M Miller; G A Hegreberg; D J Prieur; M J Hamilton
Journal:  J Hered       Date:  1984 May-Jun       Impact factor: 2.645

View more
  3 in total

1.  Congenital Myasthenic Syndrome in a Mixed Breed Dog.

Authors:  Theresa J Blakey; Jennifer R Michaels; Ling T Guo; Amy J Hodshon; G Diane Shelton
Journal:  Front Vet Sci       Date:  2017-10-17

Review 2.  Classification of myasthenia gravis and congenital myasthenic syndromes in dogs and cats.

Authors:  Thomas Mignan; Mike Targett; Mark Lowrie
Journal:  J Vet Intern Med       Date:  2020-07-15       Impact factor: 3.333

3.  A COLQ missense mutation in Labrador Retrievers having congenital myasthenic syndrome.

Authors:  Caitlin J Rinz; Jonathan Levine; Katie M Minor; Hammon D Humphries; Renee Lara; Alison N Starr-Moss; Ling T Guo; D Colette Williams; G Diane Shelton; Leigh Anne Clark
Journal:  PLoS One       Date:  2014-08-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.